Measuring the Psychosocial Burden in Women with Low-grade Abnormal Cervical Cytology in the TOMBOLA Trial: Psychometric Properties of the Process and Outcome Specific Measure (POSM)

Overview

Journal Health Qual Life Outcomes

Publisher Biomed Central

Specialty Public Health

Date 2015 Mar 14

PMID 25767846

Citations 5

Authors

Kieran Rothnie

Seonaidh C Cotton

Shona Fielding

Nicola M Gray

Julian Little

Margaret E Cruickshank

Leslie G Walker

Mark Avis

Linda Sharp

Affiliations

Soon will be listed here.

Abstract

Background: There is a need for an instrument to measure the psychosocial burden of receiving an abnormal cervical cytology result which can be used regardless of the clinical management women receive.Methods: 3331 women completed the POSM as part of baseline psychosocial assessment in a trial of management of low grade cervical cytological abnormalities. Factor analysis and reliability assessment of the POSM were conducted.Results: Two factors were extracted from the POSM: Factor 1, containing items related to worry; and Factor 2 containing items relating to satisfaction with information and support received and change in the way women felt about themselves. Factor 1 had good reliability (Cronbach's alpha 0.769), however reliability of the Factor 2 was poorer(0.482). Data collected at four subsequent time points demonstrated that the factor structure was stable over time.Conclusion: This study demonstrates the presence and reliability of a scale measuring worries within the POSM. This analysis will inform its future use in this population and in other related contexts.

Citing Articles

Psychosocial Burden of Women Who Are to Undergo Additional Diagnostic Procedures Due to Positive Screening for Cervical Cancer.

Ilic I, Babic G, Dimitrijevic A, Sipetic Grujicic S, Jakovljevic V, Ilic M Cancers (Basel). 2024; 16(20).

PMID: 39456635 PMC: 11506665. DOI: 10.3390/cancers16203541.

Depression before and after diagnostic procedures among women with abnormal finding of Papanicolaou screening test.

Ilic I, Babic G, Dimitrijevic A, Sipetic Grujicic S, Ilic M Cancer Med. 2022; 11(18):3518-3528.

PMID: 35322940 PMC: 9487877. DOI: 10.1002/cam4.4709.

The effect of an animation video on consultation time, anxiety and satisfaction in women with abnormal cervical cytology: Animation video reduces colposcopy time.

Wouters T, Soomers J, Smink M, Smit R, Plaisier M, Houterman S Prev Med Rep. 2019; 13:238-243.

PMID: 30719404 PMC: 6350223. DOI: 10.1016/j.pmedr.2019.01.005.

Consequences of screening in cervical cancer: development and dimensionality of a questionnaire.

Brodersen J, Siersma V, Thorsen H BMC Psychol. 2018; 6(1):39.

PMID: 30097013 PMC: 6086061. DOI: 10.1186/s40359-018-0251-2.

Psychosocial morbidity in women with abnormal cervical cytology managed by cytological surveillance or initial colposcopy: longitudinal analysis from the TOMBOLA randomised trial.

Fielding S, Rothnie K, Gray N, Little J, Cruickshank M, Neal K Psychooncology. 2016; 26(4):476-483.

PMID: 27297097 PMC: 5412834. DOI: 10.1002/pon.4163.

References

. EuroQol--a new facility for the measurement of health-related quality of life. Health Policy. 1990; 16(3):199-208. DOI: 10.1016/0168-8510(90)90421-9. View

Rogstad K . The psychological impact of abnormal cytology and colposcopy. BJOG. 2002; 109(4):364-8. DOI: 10.1111/j.1471-0528.2002.99023.x. View

Snaith R . The Hospital Anxiety And Depression Scale. Health Qual Life Outcomes. 2003; 1:29. PMC: 183845. DOI: 10.1186/1477-7525-1-29. View

Shinn E, Basen-Engquist K, Le T, Hansis-Diarte A, Bostic D, Martinez-Cross J . Distress after an abnormal Pap smear result: scale development and psychometric validation. Prev Med. 2004; 39(2):404-12. DOI: 10.1016/j.ypmed.2004.02.004. View

Gray N, Sharp L, Cotton S, Avis M, Philips Z, Russell I . Developing a questionnaire to measure the psychosocial impact of an abnormal cervical smear result and its subsequent management: the TOMBOLA (Trial of Management of Borderline and Other Low-grade Abnormal Smears) trial. Qual Life Res. 2005; 14(6):1553-62. DOI: 10.1007/s11136-004-8146-5. View

Cotton S, Sharp L, Little J, Duncan I, Alexander L, Cruickshank M . Trial of management of borderline and other low-grade abnormal smears (TOMBOLA): Trial design. Contemp Clin Trials. 2006; 27(5):449-71. DOI: 10.1016/j.cct.2006.04.001. View

Wright Jr T, Massad L, Dunton C, Spitzer M, Wilkinson E, Solomon D . 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol. 2007; 197(4):346-55. DOI: 10.1016/j.ajog.2007.07.047. View

Cairns M, Gray N, Cruickshank M . The impact of microinvasive cancer of the cervix on women during follow-up. Int J Gynecol Cancer. 2008; 18(6):1289-93. DOI: 10.1111/j.1525-1438.2007.01186.x. View

Lerman C, Miller S, Scarborough R, Hanjani P, Nolte S, Smith D . Adverse psychologic consequences of positive cytologic cervical screening. Am J Obstet Gynecol. 1991; 165(3):658-62. DOI: 10.1016/0002-9378(91)90304-a. View

10.

Mast T, Zhu X, Demuro-Mercon C, Cummings H, Sings H, Ferris D . Development and psychometric properties of the HPV Impact Profile (HIP) to assess the psychosocial burden of HPV. Curr Med Res Opin. 2009; 25(11):2609-19. DOI: 10.1185/03007990903238786. View

11.

. ACOG Practice Bulletin no. 109: Cervical cytology screening. Obstet Gynecol. 2010; 114(6):1409-1420. DOI: 10.1097/AOG.0b013e3181c6f8a4. View

12.

Zeisler H, Mayerhofer K, Joura E, Sator M, Kainz C . Psychological burden of women with mild cervical intraepithelial neoplasia. Oncol Rep. 2011; 4(5):1063-5. DOI: 10.3892/or.4.5.1063. View

13.

Marteau T, Walker P, Giles J, Smail M . Anxieties in women undergoing colposcopy. Br J Obstet Gynaecol. 1990; 97(9):859-61. DOI: 10.1111/j.1471-0528.1990.tb02586.x. View

14.

Korfage I, van Ballegooijen M, Wauben B, Looman C, Habbema J, Essink-Bot M . Having a Pap smear, quality of life before and after cervical screening: a questionnaire study. BJOG. 2012; 119(8):936-44. DOI: 10.1111/j.1471-0528.2012.03344.x. View

15.

Lockhart J, Gray N, Cruickshank M . The development and evaluation of a questionnaire to assess the impact of vulval intraepithelial neoplasia: a questionnaire study. BJOG. 2013; 120(9):1133-42. DOI: 10.1111/1471-0528.12229. View

16.

Cattell R . The Scree Test For The Number Of Factors. Multivariate Behav Res. 2016; 1(2):245-76. DOI: 10.1207/s15327906mbr0102_10. View

17.

Zigmond A, SNAITH R . The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983; 67(6):361-70. DOI: 10.1111/j.1600-0447.1983.tb09716.x. View

18.

Bennetts A, Irwig L, Oldenburg B, Simpson J, Mock P, Boyes A . PEAPS-Q: a questionnaire to measure the psychosocial effects of having an abnormal pap smear. Psychosocial Effects of Abnormal Pap Smears Questionnaire. J Clin Epidemiol. 1995; 48(10):1235-43. DOI: 10.1016/0895-4356(95)00015-v. View

19.

Roberts R, Blunt S . The psychological reaction of women to a colposcopy clinic. Br J Obstet Gynaecol. 1994; 101(9):751-2. DOI: 10.1111/j.1471-0528.1994.tb11939.x. View

20.

Lerman C, Rimer B . Psychosocial impact of cancer screening. Oncology (Williston Park). 1993; 7(4):67-72; discussion 72, 75, 79. View